WAM Capital Limited (ASX:WAM) Reports Strong Portfolio Performance and Maintains Interim Dividend
WAM Capital (ASX:WAM) outperforms key indices by up to 9.4%, declares a 7.75c interim dividend, driven by a robust investment portfolio.
WAM Capital (ASX:WAM) outperforms key indices by up to 9.4%, declares a 7.75c interim dividend, driven by a robust investment portfolio.
AMP Limited (ASX:AMP) reports a 15.1% increase in underlying NPAT for FY24, alongside cost reductions and a final dividend declaration.
AVITA Medical (ASX:AVH) reports a 30% revenue increase in Q4 and FDA approvals, setting the stage for significant growth in FY 2025.
Cochlear Limited (ASX:COH) reports a 5% revenue increase and an 8% interim dividend rise for the half year ended December 2024.
Unibail-Rodamco-Westfield (ASX:URW) reports robust FY-2024 earnings with increased EBITDA and proposes a significant distribution hike.
Ten Sixty Four Limited (ASX:X64) effectuates its Deed of Company Arrangement, exiting external administration and restoring director control.
Pure Foods Tasmania Ltd (ASX:PFT) responds to ASX’s financial queries, detailing loan extensions, debt repayments, and a comprehensive turnaround plan.
Hancock & Gore Limited (ASX:HNG) highlights a 13% profit increase and a strategic merger with Schoolblazer at their 121st AGM.
Tivan Limited (ASX:TVN) advances the Sandover Fluorite Project with high-grade assays and plans Q4 2025 drilling.
Althea Group Holdings (ASX:AGH) revises its FY25 revenue guidance to $26-$33 million and adjusts EBITDA expectations amidst strategic restructuring.